Stryker Corp.
SYK
Market Cap$141.61B
Close$
Earnings Call Q4 2024
January 28, 2025 - AI Summary
Strong Q4 and Full Year Performance: Stryker reported Q4 organic sales growth of 10.2% and full-year growth of 10.2%, maintaining strong momentum amidst previous double-digit growth comparisons. Adjusted EPS grew by 16% in Q4 and 15% for the full year, with figures of $4.01 and $12.19, respectively.
Guidance for 2025: Stryker projects organic sales growth for 2025 to be between 8% and 9% with continued operating margin expansion. EPS is expected to be in the range of $13.45 to $13.70, which indicates robust growth potential despite the expected dilution from the upcoming Inari acquisition.
Inari Acquisition and Strategic Rationale: The acquisition of Inari Medical for $4.9 billion is aimed at strengthening Stryker’s position in the peripheral vascular market. Growth in this segment is backed by strong clinical data and a relatively untapped $15 billion market opportunity, suggesting potential for future sales growth.
Exclusive for Stockcircle Pro members
Sign up
$304.78
18.6% downside
Current Fair Value
18.6% downsideOvervalued by 18.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $141.61 Billion |
|---|---|
| Enterprise Value | $150.49 Billion |
| Dividend Yield | $3.24 (0.873056506157204%) |
| Earnings per Share | $7.86 |
| Beta | 0.96 |
| Outstanding Shares | 381,000,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 47.24 |
|---|---|
| PEG | -90.45 |
| Price to Sales | 6.34 |
| Price to Book Ratio | 3.34 |
| Enterprise Value to Revenue | 6.66 |
| Enterprise Value to EBIT | 40.72 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Stryker Corp.
40,000 employees
CEO: Kevin Lobo Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neur...